» Authors » Andre Tichelli

Andre Tichelli

Explore the profile of Andre Tichelli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 151
Citations 4663
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Dalla Via V, Halter J, Gerull S, Arranto C, Tichelli A, Heim D, et al.
In Vivo . 2020 Nov; 34(6):3545-3549. PMID: 33144466
Background: Survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has increased but so have long-term sequelae. New-onset post-transplant diabetes mellitus (PTDM) occurs frequently following allo-HSCT. Patients And Methods: Study endpoints...
12.
Drexler B, Zurbriggen F, Diesch T, Viollier R, Halter J, Heim D, et al.
Ann Hematol . 2020 Sep; 99(11):2529-2538. PMID: 32948913
Introduction: Since the 1970s outcome of aplastic anemia (AA) patients has improved significantly due to the introduction of immunosuppressive therapy (IST) and allogeneic hematopoietic transplantation (HCT). However, patients may suffer...
13.
Weisshaar K, Ewald H, Halter J, Gerull S, Schonfeld S, Senft Y, et al.
Orphanet J Rare Dis . 2020 Sep; 15(1):249. PMID: 32943103
Background: The introduction of new therapy modalities has significantly improved the outcome of aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) patients. However, relatively little is known about the exact...
14.
Drexler B, Tichelli A, Passweg J
Ther Umsch . 2020 Mar; 76(9):523-529. PMID: 32157970
Bone marrow failure Bone marrow failure involves a heterogeneous spectrum of rare benign hematological disorders caused by an impaired bone marrow function. Bone marrow failure can be acquired (acquired aplastic...
15.
Tichelli A, Peffault de Latour R, Passweg J, Knol-Bout C, Socie G, Marsh J, et al.
Haematologica . 2019 Oct; 105(5):1223-1231. PMID: 31582549
This follow-up study of a randomized, prospective trial included 192 patients with newly diagnosed severe aplastic anemia receiving antithymoglobulin and cyclosporine, with or without granulocyte colony-stimulating factor (G-CSF). We aimed...
16.
Tichelli A, Socie G, Salooja N
JAMA Oncol . 2019 May; 5(7):1064-1065. PMID: 31070680
No abstract available.
17.
Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, et al.
Bone Marrow Transplant . 2019 Feb; 54(5):782-783. PMID: 30809032
In the original version of this article, author 'Aisha Al-Khinji' was incorrectly listed as 'Aisha Ahmed'. This has now been corrected in both the PDF and HTML versions of the...
18.
Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, et al.
Bone Marrow Transplant . 2018 Dec; 54(5):648-661. PMID: 30531955
Non-graft-vs.-host disease (non-GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT), but can cause prolonged morbidity affecting activities of daily living and quality of life. Here we provide...
19.
Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, et al.
Biol Blood Marrow Transplant . 2018 Dec; 25(5):e145-e154. PMID: 30521975
Non-graft-versus-host disease (GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT) but can cause prolonged morbidity affecting activities of daily living and quality of life. Here we provide...
20.
Tichelli A, Beohou E, Labopin M, Socie G, Rovo A, Badoglio M, et al.
JAMA Oncol . 2018 Nov; 5(2):229-235. PMID: 30476975
Importance: Incidence and risk factors of second solid cancers (SSCs) that occur after hematopoietic stem cell transplantation (HSCT) are well documented. However, clinical outcome data of patients who developed an...